| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.19 | 7e-05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.077 | 0.08 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.076 | 0.09 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.069 | 0.1 |